The First Cannabis-Based Drug in The US Has Been Recommended by FDA Panel

Posted by on April 20, 2018 in Hazards, Issues & Diseases, Health with 0 Comments

(Kathy Young/AP)

By Laurie McGinley | Science Alert

Food and Drug Administration advisers on Thursday unanimously supported the first government approval of a medication made from cannabis, paving the way for agency clearance by the end of June.

The drug, Epidiolex, would be administered in a syrup form and is made from a purified ingredient in cannabis called cannabidiol, or CBD.


It is intended to treat severe seizures in children caused by rare forms of epilepsy called Lennox-Gastaut and Dravet syndromes.

Most patients with those diseases have uncontrolled daily seizures despite treatment, putting them at high risk for developmental disabilities, serious injury and premature death, the FDA staff said in background materials released this week.

The unanimous support of the 13-member FDA advisory committee seemed assured after agency staff members gave the drug a positive review, saying that clinical trials showed that it was effective at reducing seizures and that side effects, including possible liver complications, could be managed.

The precise mechanism by which CBD reduces seizures isn’t known, the FDA said.

The drug does not contain THC, the psychoactive component in cannabis. The FDA staff said that the drug “has a negligible abuse potential.”


The FDA isn’t required to follow the recommendation of its outside advisers but usually does. The agency has indicated it would act by late June on the application from GW Pharmaceuticals, a British company that would market the drug.

An FDA approval would be targeted to specific epilepsy patients, but once approved, the drug could be prescribed for other uses. And it could pave the way for other cannabis-based drugs, analysts say.

Several parents whose children have been participating in clinical trials of the drug said that their children’s lives have been transformed by the medication.

Polly Vanderwoude said her daughter, Olivia, began having seizures in 2010 when she was 2 months old, and had multiple seizures a day. But since Olivia began taking Epidiolex in 2014, her mother said, there have been “great improvements,” including many days when she did not have any seizures at all.

In addition, her daughter now is smiling and making eye contact, and has closer relationships with family members, Vanderwoude said.

“It has been a lifeline,” Vanderwoude said.

Michael Privitera, a neurologist at the University of Cincinnati Medical Center who was involved in the testing of the drug, said it was a major advance, and that it was important that the drug be approved so that parents don’t have to buy CBD from medical marijuana dispensaries, which don’t necessarily know the quality of CBD products or the recommended dose.

2018 © The Washington Post

This article was originally published by The Washington Post.

Read more great articles at Science Alert.

Tags: , , , , , ,

Subscribe

If you enjoyed this article, subscribe now to receive more just like it.

Subscribe via RSS Feed Connect on YouTube

New Title

NOTE: Email is optional. Do NOT enter it if you do NOT want it displayed.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

FAIR USE NOTICE. Many of the articles on this site contain copyrighted material whose use has not been specifically authorized by the copyright owner. We are making this material available in an effort to advance the understanding of environmental issues, human rights, economic and political democracy, and issues of social justice. We believe this constitutes a 'fair use' of the copyrighted material as provided for in Section 107 of the US Copyright Law which contains a list of the various purposes for which the reproduction of a particular work may be considered fair, such as criticism, comment, news reporting, teaching, scholarship, and research. If you wish to use such copyrighted material for purposes of your own that go beyond 'fair use'...you must obtain permission from the copyright owner. And, if you are a copyright owner who wishes to have your content removed, let us know via the "Contact Us" link at the top of the site, and we will promptly remove it.

The information on this site is provided for educational and entertainment purposes only. It is not intended as a substitute for professional advice of any kind. Conscious Life News assumes no responsibility for the use or misuse of this material. Your use of this website indicates your agreement to these terms.

Paid advertising on Conscious Life News may not represent the views and opinions of this website and its contributors. No endorsement of products and services advertised is either expressed or implied.
Top

Send this to friend